v3.25.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash Flows from Operating Activities    
Net loss $ (28,934,519) $ (1,303,903)
Adjustments to reconcile net loss to net cash used by operating activities    
Depreciation and amortization 337,259 368,301
Loss on disposal of property and equipment 18,846
Noncash lease expense 254,695 193,281
Bad debt (recovery)/expense (7,367) 11,964
Contract modification - related party 280,545
Share-based compensation 4,087 7,557
Shares issued to pay for services 40,000
Accrued interest on notes payable 262,107 327,132
Non-cash royalty income (13,797) (13,282)
Amortization of original issue discounts on notes payable 4,167
Loan origination costs 5,000 18,133
Loss on exercise of warrant liabilities 15,796,105
Changes in fair value of warrant liability 10,020,212
Changes in operating assets and liabilities net of effects from acquisition    
Trade receivables 1,964,241 (696,824)
Trade receivables - related party 66,057 (163,349)
Inventory (4,126,906) 800,602
Contract assets (556,032) 45,066
Prepaid expenses and other current assets 261,559 636,906
Other assets 157,699 (54,592)
Accounts payable (1,051,056) (2,072,392)
Accounts payable - related party 221
Sales tax payable (63,509) (25,116)
Operating lease liabilities (256,271) (193,130)
Deposits from customers (88,285) 26,179
Accrued expenses 4,743,926 (941,698)
Contract liabilities 24,981 8,406
Deferred revenue (188,930) (54,982)
Income taxes payable (149,142) (7,823)
Other liabilities 32,511 (95,730)
Net cash used by operating activities (1,201,817) (3,139,073)
Cash Flows from Investing Activities    
Purchase of property and equipment (924,428) (290,666)
Proceeds from sale of property and equipment 5,529
Royalties on related party revenues 10,000
Proceeds from sale of marketable securities 356
Investment in MasterpieceVR (100,000) (100,000)
Net cash used by investing activities (1,008,899) (390,310)
Cash Flows from Financing Activities    
Proceeds on revolving line of credit 7,025,841 11,655,935
Payments on revolving line of credit (6,053,954) (8,371,144)
Payments on debt (124,912) (2,304,903)
Payments on Paycheck Protection Program Loans (10,123) (10,120)
Proceeds on bank loans 28,331
Proceeds from notes payable 500,000
Proceeds from warrant exercises 1,050,597
Net cash provided by financing activities 2,387,449 998,099
Effect of currency translation (132,871) 198,454
Net decrease in cash, cash equivalents, and restricted cash 176,733 (2,531,284)
Cash, cash equivalents, and restricted cash at beginning of period 5,420,392 6,349,562
Total cash, cash equivalents, and restricted cash 5,464,254 4,016,732
Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash    
Cash and cash equivalents 4,224,130 2,835,216
Restricted cash 1,240,124 1,181,516
Supplemental Disclosure of Cash Flow Information:    
Cash paid during the period for interest 217,639 238,418
Cash paid during the period for income taxes, net of refunds 269,680 176,378
Supplemental Schedule of Non-Cash Investing and Financing Activities    
Shares issued to pay for services 40,000
Financing of fixed asset purchase 28,331
Series A Warrant Exercises 21,515,777
Noncash recognition of new leases $ 159,086

Source

PDF HTML
ZIP XBRL